143 related articles for article (PubMed ID: 37014588)
21. Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.
Nishibeppu K; Komatsu S; Ichikawa D; Imamura T; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
BMC Cancer; 2018 Jan; 18(1):108. PubMed ID: 29382310
[TBL] [Abstract][Full Text] [Related]
22. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
Lu W; Zeng X; Li N; Liu H
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
[TBL] [Abstract][Full Text] [Related]
23. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of tumor deposits in lymph node-negative gastric cancer: A propensity score matching study.
Xu R; Zhang Y; Zhao J; Chen K; Wang Z
Eur J Surg Oncol; 2023 Apr; 49(4):845-852. PubMed ID: 36543660
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative Gastrectomy.
Bilici A; Selcukbiricik F; Seker M; Oven BB; Olmez OF; Yildiz O; Olmuscelik O; Hamdard J; Acikgoz O; Cakir A; Kapran Y; Balik E; Oncel M
Oncol Res Treat; 2019; 42(4):209-216. PubMed ID: 30870846
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of venous invasion in stage IB node-negative gastric cancer.
Araki I; Hosoda K; Yamashita K; Katada N; Sakuramoto S; Moriya H; Mieno H; Ema A; Kikuchi S; Mikami T; Watanabe M
Gastric Cancer; 2015 Apr; 18(2):297-305. PubMed ID: 24687437
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
[TBL] [Abstract][Full Text] [Related]
28. Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach.
Wang HM; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J
World J Gastroenterol; 2012 Oct; 18(38):5470-5. PubMed ID: 23082065
[TBL] [Abstract][Full Text] [Related]
29. [Prognosis analysis of 310 patients with pathological stage pN3 gastric cancer].
Ke B; Liu N; Liang H; Zhang RP; Wang XJ; Wu LL
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):543-6. PubMed ID: 23801207
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of risk factors and prognosis of No.8p lymph node metastasis in cases with advanced gastric cancer].
Chen L; Wei S; Ye Z; Zeng Y; Zheng Q; Xiao J; Wang Y; Zhuo C; Lin Z; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):218-223. PubMed ID: 28226359
[TBL] [Abstract][Full Text] [Related]
31. Impact of extranodal extension on prognosis in lymph node-positive gastric cancer.
Lee IS; Park YS; Ryu MH; Song MJ; Yook JH; Oh ST; Kim BS
Br J Surg; 2014 Nov; 101(12):1576-84. PubMed ID: 25223244
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of tumor deposits in gastric cancer after radical gastrectomy: a propensity score matching study.
Song X; Liu K; Liao X; Zhu Y; Peng B; Zhang W; Zhao L; Chen X; Yang K; Hu J
World J Surg Oncol; 2023 Oct; 21(1):325. PubMed ID: 37833750
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and prognosis of gastric cancer in patients aged ≥ 70 years.
Liang YX; Deng JY; Guo HH; Ding XW; Wang XN; Wang BG; Zhang L; Liang H
World J Gastroenterol; 2013 Oct; 19(39):6568-78. PubMed ID: 24151383
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
Li F; Wang Y; Li C; Ma Y; Zhang Y; Li Z; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):529-534. PubMed ID: 29774934
[TBL] [Abstract][Full Text] [Related]
35. Consideration of tumor size improves the accuracy of TNM predictions in patients with gastric cancer after curative gastrectomy.
Lu J; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX
Surg Oncol; 2013 Sep; 22(3):167-71. PubMed ID: 23787074
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
37. Tumor deposit serves as a prognostic marker in gastric cancer: A propensity score-matched analysis comparing survival outcomes.
Wenquan L; Yuhua L; Jianxin C; Hongqing X; Kecheng Z; Jiyang L; Yunhe G; Yi L; Wang Z; Shaoqing L; Yixun L; Shen Q; Wanguo X; Zhi Q; Lin C
Cancer Med; 2020 May; 9(10):3268-3277. PubMed ID: 32163670
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
[No Abstract] [Full Text] [Related]
39. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
[TBL] [Abstract][Full Text] [Related]
40. Recurrence patterns after curative gastrectomy for pStage II/III gastric cancer: Exploratory analysis of the randomized controlled JCOG1001 trial.
Toriumi T; Terashima M; Mizusawa J; Sato Y; Kurokawa Y; Takiguchi S; Doki Y; Shinohara H; Teshima S; Yasuda T; Ito S; Yoshikawa T; Sano T; Sasako M
Eur J Surg Oncol; 2023 Apr; 49(4):838-844. PubMed ID: 36424261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
